Linking inflammation and thrombosis: Role of C-reactive protein

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Immunology

Background:

• C-reactive protein (CRP) is a well-established biomarker for inflammation.
• Elevated plasma CRP levels correlate with increased risk of myocardial infarction (MI).
• The association between CRP concentration and atherosclerotic plaque burden is weak, suggesting alternative mechanisms for CRP's role in MI.

Purpose of the Study:

• To review existing data linking C-reactive protein (CRP) to thrombosis.
• To investigate the hypothesis that CRP promotes myocardial infarction (MI) by enhancing thrombosis.
• To focus on CRP's impact on hemostasis, platelet activity, and fibrinolysis.

Main Methods:

• Literature review of studies investigating the relationship between CRP and thrombosis.
• Analysis of data on CRP's effects on hemostatic pathways.
• Examination of research on CRP's influence on platelet function.
• Review of studies assessing CRP's role in fibrinolysis.

Main Results:

• Available data indicate a link between increased CRP expression and a higher risk of thrombosis.
• CRP influences key components of hemostasis, including coagulation.
• CRP affects platelet activation and aggregation.
• CRP impacts the fibrinolytic system, influencing clot stability and breakdown.

Conclusions:

• The findings support the hypothesis that CRP is a critical mechanistic link between inflammation and thrombosis.
• CRP's pro-thrombotic effects provide a plausible explanation for its association with myocardial infarction risk.
• Targeting CRP-mediated pathways may offer novel therapeutic strategies for cardiovascular disease prevention.